Drug Information Association Logo

Unique Value: How to Differentiate and Measure

Track:
Medical Science Liasons Track

Day & Time:
March 12, 10:00AM - 11:30AM

Room Number:
Regency Hall 1 & 2

Type:
Session

Title:
Unique Value: How to Differentiate and Measure

Chair(s):
Randy David Miller, PharmD, RPh
Director, Field Based Medicine Operations
Boehringer Ingelheim Pharmaceuticals, Inc., United States

Description:
This session is focused on providing insights into key value drivers for MSL programs that have demonstrated success and unique value to internal and external stakeholders. The panel will address both current and future drivers, focusing on evolving areas where MSLs can provide unique value in our rapidly changing healthcare system and commercial marketplace.

Learning Objective(s):
Evaluate MSL activities and tactics that are unique to the MSL role where internal and external stakeholders have found the greatest value
Discuss the challenges in differentiating the value of MSLs as teams face an increasing presence of new and unique field facing teams (clinical trial liaisons, outcomes, advocacy, nurse educators, others) in response to the changing commercial and regulatory landscape

Presentation(s) & Speaker(s):
Unique Value: How to Differentiate and Measure
Randy David Miller, PharmD, RPh
Director, Field Based Medicine Operations
Boehringer Ingelheim Pharmaceuticals, Inc., United States

Unique Value: How to Differentiate and Measure
Hilary D. Mandler, PharmD
Director, Global MSL Operations
Shire PLC, United States

Unique Value: How to Differentiate and Measure
David A. Jencen, PhD
Principal
Jencen Field Medical Consulting LLC, United States

© 2014 DIA